Efrosini Kokkoli, PhD

University of Minnesota, Twin Cities

420 Delaware St. SE

Minneapolis, MN 55455

United States

SCHOLARLY PAPERS

6

DOWNLOADS
Rank 47,359

SSRN RANKINGS

Top 47,359

in Total Papers Downloads

626

CITATIONS
Rank 25,439

SSRN RANKINGS

Top 25,439

in Total Papers Citations

10

Scholarly Papers (6)

1.

Exploring Emerging Nanobiotechnology Drugs and Medical Devices

Food & Drug Law Journal, Vol. 63, No. 2, pp. 407-420, 2008
Number of pages: 15 Posted: 05 Jun 2008
Jordan Paradise, Gail Diliberto, Alison Tisdale and Efrosini Kokkoli, PhD
Loyola University Chicago School of Law, University of Minnesota - Twin Cities - Dept of Sociology, University of Minnesota - Twin Cities - Dept of Sociology and University of Minnesota, Twin Cities
Downloads 170 (133,253)
Citation 3

Abstract:

nanotechnology, FDA, drugs, medical devices, combination products, regulation

2.

Developing Oversight Frameworks for Nanobiotechnology

Minnesota Journal of Law, Science & Technology, Vol. 9, No. 1, pp. 187-203, 2008
Number of pages: 17 Posted: 09 Mar 2008 Last Revised: 18 Nov 2014
Loyola University Chicago School of Law, University of Minnesota Law School, University of Minnesota, Twin Cities, University of Minnesota, Twin Cities, University of Minnesota, Twin Cities - School of Law and University of Minnesota, Twin Cities - Hubert H. Humphrey Institute of Public Affairs
Downloads 129 (171,638)
Citation 1

Abstract:

nanotechnology, regulation, oversight, federal agencies

3.

Recommendations for Oversight of Nanobiotechnology: Dynamic Oversight for Complex and Convergent Technology

Journal of Nanoparticle Research, Vol. 13, pp. 1345-1371, 2011
Number of pages: 47 Posted: 23 Jan 2011 Last Revised: 28 Jul 2013
University of Minnesota, Twin Cities, University of Minnesota Law School, Loyola University Chicago School of Law, University of Minnesota, Twin Cities - Hubert H. Humphrey Institute of Public Affairs, University of Minnesota, Twin Cities - School of Law, University of Minnesota, Twin Cities and University of Minnesota - Twin Cities - Hubert H. Humphrey Institute of Public Affairs
Downloads 118 (178,033)
Citation 1

Abstract:

Science Oversight, Technology Oversight, Dynamic Oversight, New Governance, Science Regulation, Technology Regulation, Nanotechnology, Nanobiotechnology, NNI, FDA, EPA, OSHA, NIOSH, NIH, OSTP, Law and Science, Bioethics

The Challenge of Developing Oversight Approaches to Nanobiotechnology

Journal of Law, Medicine & Ethics, Vol. 37, pp. 543-545, 2009
Number of pages: 3 Posted: 01 Jul 2010 Last Revised: 27 Apr 2012
Loyola University Chicago School of Law, University of Minnesota Law School, University of Minnesota, Twin Cities - Hubert H. Humphrey Institute of Public Affairs, University of Minnesota, Twin Cities and University of Minnesota, Twin Cities
Downloads 47 (326,987)
Citation 2

Abstract:

nanotechnology, nanobiotechnology, United States, oversight, law

5.

Developing U.S. Oversight Strategies for Nanobiotechnology: Learning from Past Oversight Experiences

Journal of Law, Medicine & Ethics, Vol. 37, No. 4, pp. 688-705, Winter 2009
Number of pages: 18 Posted: 30 Jun 2010 Last Revised: 18 Nov 2014
Loyola University Chicago School of Law, University of Minnesota Law School, University of Minnesota, Twin Cities - Hubert H. Humphrey Institute of Public Affairs, University of Minnesota - Twin Cities, University of Minnesota - Twin Cities - Dept of Sociology, University of Minnesota, Twin Cities and University of Minnesota, Twin Cities
Downloads 77 (242,857)
Citation 2

Abstract:

6.

Evaluating Oversight of Human Drugs and Medical Devices: A Case Study of the FDA and Implications for Nanobiotechnology

Journal of Law, Medicine & Ethics, Vol. 37, No. 4, pp. 598-624, Winter 2009
Number of pages: 27 Posted: 30 Jun 2010
Jordan Paradise, Alison Tisdale, Ralph Hall, JD and Efrosini Kokkoli, PhD
Loyola University Chicago School of Law, University of Minnesota - Twin Cities - Dept of Sociology, University of Minnesota, Twin Cities - School of Law and University of Minnesota, Twin Cities
Downloads 53 (289,287)
Citation 1

Abstract:

Food and Drug Administration, nanotechnology, nanobiotechnology, drugs, medical devices, oversight